Pharmacy Technician Certification Examination® (PTCE®) Content Outline
Effective Date
- The outlined content is effective as of January 6, 2026.
Knowledge Domains and Areas and Their Percentage of PTCE® Exam Content
1. Medications (35%)
- 1.1 Generic names, brand names, and classifications of medications
- 1.2 Therapeutic duplications
- 1.3 Common or life-threatening drug interactions and contraindications, including
- Drug-drug interactions
- Drug-dietary supplement interactions
- Drug-laboratory interactions
- Drug-nutrient interactions
- Drug-disease interactions
- 1.4* Strengths/doses, dosage forms, routes of administration, special handling and administration instructions, and duration of drug therapy
- 1.5 Common or severe medication side effects, adverse effects, and allergies
- 1.6 Indications of medications
- 1.7* Drug stability, including
- Oral suspensions
- Insulins
- Reconstitutables
- Injectables
- Vaccinations
- 1.8 Proper storage of medications, focusing on
- Temperature ranges
- Light sensitivity
- Restricted access
2. Federal Requirements (18.75%)
- 2.1 Federal requirements for the storage, handling, and disposal of
- Non-hazardous
- Hazardous (e.g., P-list) substances
- Pharmacological substances and wastes
- 2.2* Federal requirements for controlled substance prescriptions
- New prescriptions
- Refills
- Transfers
- Mention of DEA controlled substance schedules
- 2.3 Federal requirements concerning
- Receiving and storing controlled substances
- Ordering and labeling controlled substances
- Dispensing, returning, take-back programs for controlled substances
- Loss or theft of controlled substances
- Destruction of controlled substances
- 2.4* Federal restricted drug programs and related medication-processing requirements, such as
- Pseudoephedrine regulations
- Risk Evaluation and Mitigation Strategies (REMS)
- 2.5 FDA requirements for medication recalls
- 2.6 FDA product serialization, tracking, tracing, handling, and quarantining requirements, referencing
- Drug Supply Chain Security Act (DSCSA)
3. Patient Safety and Quality Assurance (23.75%)
- 3.1 High-alert/risk medications and look-alike/sound-alike (LASA) medications
- 3.2 Error prevention strategies such as
- Correcting patient prescriptions or medication orders
- Use of Tall Man lettering
- Separation of inventory
- Use of leading and trailing zeros
- Bar code usage
- Limiting the use of error-prone abbreviations
- 3.3* Issues that require pharmacist intervention, for instance
- Drug utilization review (DUR)
- Adverse drug events (ADE)
- Over-the-counter medication recommendations
- Therapeutic substitution
- Misuse and adherence
- Post-immunization delivery care
- Allergies and drug interactions
- 3.4 Event reporting procedures including
- Reporting medication errors and adverse effects
- Product integrity concerns
- MedWatch, VAERS (Vaccine Adverse Event Reporting System)
- Near misses
- Root-cause analysis (RCA)
- Continuous quality improvement (CQI)
- 3.5* Types of prescription errors, including
- Incorrect dose
- Incorrect quantity
- Incorrect patient
- Incorrect drug
- Incorrect route of administration
- 3.6 Infection prevention procedures and cleaning standards encompassing
- Handwashing
- Use of personal protective equipment (PPE)
- Cleaning counting trays, countertops, and equipment
4. Order Entry and Processing (22.50%)
- 4.1* Formulas, calculations, ratios, proportions, and conversions, including
- Sig codes (e.g., b.i.d., t.i.d., Roman numerals)
- Abbreviations, medical terminology, and symbols for days supply, quantity, dose, concentration, and dilutions
- 4.2* Equipment and supplies required for drug administration, such as
- Diabetic supplies
- Inhaler spacers
- Oral syringes
- Injectable syringes
- Filters and dilution solutions
- Immunization supplies
- Nebulizers
- 4.3* Lot numbers, expiration dates, and National Drug Code (NDC) numbers
- 4.4 Procedures for identifying and returning dispensable, non-dispensable, and expired medications and supplies, including
- Credit return
- Return to stock
- Reverse distribution